Uric acid and xanthine oxidase in heart failure - Emerging data and therapeutic implications.
about
Reactive Oxygen Species/Nitric Oxide Mediated Inter-Organ Communication in Skeletal Muscle Wasting Diseases.Close linkage between serum uric acid and cardiac dysfunction in patients with ischemic heart disease according to covariance structure analysisMeasurement and Clinical Significance of Biomarkers of Oxidative Stress in Humans.Uric acid in the pathogenesis of metabolic, renal, and cardiovascular diseases: A review.Safety and effect of high dose allopurinol in patients with severe left ventricular systolic dysfunction.Uric Acid Is Associated With Inflammation, Coronary Microvascular Dysfunction, and Adverse Outcomes in Postmenopausal Women.The impact of cardiac resynchronization therapy on routine laboratory parameters.Evaluation of the Effectiveness of Xanthine Oxidoreductase Inhibitors on Haemodialysis Patients using a Marginal Structural Model.Serum uric acid as a potential marker for heart failure risk in men on antihypertensive treatment: The British Regional Heart Study.An analysis of the types of recently published research in the field of cachexia.Allopurinol and the risk of incident peripheral arterial disease in the elderly: a US Medicare claims data study.Uric acid is important, but there is something that matters even more: to deliver sacubitril/valsartan to eligible heart failure patients.
P2860
Q30275433-85B18A19-0A1F-420E-8360-C72840A04C2BQ33740348-45CAC9EB-77D9-419A-8F2B-6E9FC19793CFQ33862472-74630A81-E9F5-44F2-8D17-A36177C2D652Q34682703-907908A0-4B04-47B9-A317-C657AAE31476Q38652335-2A792727-E4DF-4ABE-9A52-9013C9D4E839Q40417250-E0DA4D75-50BA-4D82-BA2C-9FB23C5E93C4Q41105358-8B23E7D8-B522-4A85-A56F-6689DBDFB76BQ42630143-100F8600-9763-46EE-9CA5-BFE93B762515Q47326970-0B225763-99BA-4877-B07A-4C621E81B297Q47568983-FE96C57E-103E-4B2D-B57A-B30EE1D35807Q47589109-F73076E8-F43B-4275-B7F8-41313962FFFAQ50071139-0D0594B5-12D7-40B8-84BA-E2BB5D8AD3DA
P2860
Uric acid and xanthine oxidase in heart failure - Emerging data and therapeutic implications.
description
2015 nî lūn-bûn
@nan
2015 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Uric acid and xanthine oxidase ...... and therapeutic implications.
@ast
Uric acid and xanthine oxidase ...... and therapeutic implications.
@en
type
label
Uric acid and xanthine oxidase ...... and therapeutic implications.
@ast
Uric acid and xanthine oxidase ...... and therapeutic implications.
@en
prefLabel
Uric acid and xanthine oxidase ...... and therapeutic implications.
@ast
Uric acid and xanthine oxidase ...... and therapeutic implications.
@en
P50
P1476
Uric acid and xanthine oxidase ...... and therapeutic implications.
@en
P2093
Jochen Springer
Wolfram Doehner
P356
10.1016/J.IJCARD.2015.08.089
P577
2015-08-11T00:00:00Z